The selective estrogen receptor degrader giredestrant plus palbociclib (Ibrance) did not significantly improve progression-free survival (PFS) in advanced hormone receptor-positive/HER2-negative ...

Doctors warn colon cancer is rising in younger adults after a 28-year-old mother's symptoms were initially mistaken for haemorrhoids.

Radiopharm Theranostics maintains a "Hold" rating as its radiotherapeutic pipeline advances, with key data readouts expected in 2026. Click here to read.

A new study finds that a significant portion of older adults with mild cognitive impairment or dementia develop new ...